Mode
Text Size
Log in / Sign up
Phase 4 Completed N=122 Randomized Triple-blind Supportive Care

Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty

Arthritis of Hip
Source: ClinicalTrials.gov NCT03375112 ↗
Enrolled (actual)
122
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcomePrimary: Averaged Pain Score — 3.75; 4.11 score on a scale
◆ Published Evidence
Established
34citations · ~6 / year
Pain Control After Total Hip Arthroplasty: A Randomized Controlled Trial Determining Efficacy of Fascia Iliaca Compartment Blocks in the Immediate Postoperative Period.
The Journal of arthroplasty · 2020 · Likely link

Summary

The fascia iliaca compartment block (FICB) is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip. The purpose of this study is to determine whether FICB can reduce postoperative pain and increase progress with physical therapy after total hip arthroplasty (THA). This randomized, double-blind, clinical trial will randomize patients to receive either a FICB or placebo after THA. The primary outcomes will be pain scores reported by the patient post-operatively.

Linked Publications

  • Pain Control After Total Hip Arthroplasty: A Randomized Controlled Trial Determining Efficacy of Fascia Iliaca Compartment Blocks in the Immediate Postoperative Period.
    The Journal of arthroplasty · 2020 · 34 citations · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Averaged Pain Score
3.75; 4.11
PRIMARY
Morphine Equivalents Consumed
75.3; 86.0
SECONDARY
Walking Distance
67.1; 68.3
SECONDARY
Time to Up-and-go
63.7; 66.3
SECONDARY
Time to Discharge Readiness
35.1; 35.2

Eligibility Criteria

Inclusion Criteria

  • Patients over the age of 18
  • Scheduled for total hip arthroplasty at Henry Ford Hospital
  • Epidural anesthesia during surgery

Exclusion Criteria

  • Pregnancy
  • Known intolerance to local anesthetic or narcotics
  • Revision hip surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03375112) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search